The Role of Contactin 1 in Cancers: What We Know So Far

Cancers are among the difficult-to-treat diseases despite advances in diagnosis and treatment. Although newer effective targets remain to be discovered, targeted therapy has emerged as a promising field. In the last decade, contactin 1 (CNTN1) has surfaced as an important cancer-related molecule. CN...

Full description

Saved in:
Bibliographic Details
Published in:Frontiers in oncology 2020-10, Vol.10, p.574208-574208
Main Authors: Liang, Yumei, Ma, Cui, Li, Fengjuan, Nie, Guanhua, Zhang, Haining
Format: Article
Language:English
Subjects:
cancers
contactin 1 (CNTN1)
epithelial-mesenchymal transition (EMT)
Oncology
PI3K/AKT
signal transduction pathways
targeted therapy
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Cancers are among the difficult-to-treat diseases despite advances in diagnosis and treatment. Although newer effective targets remain to be discovered, targeted therapy has emerged as a promising field. In the last decade, contactin 1 (CNTN1) has surfaced as an important cancer-related molecule. CNTN1 is a neuronal membrane glycoprotein, which, if overexpressed, is found in different cancer cell lines, cancer tissues, and transgenic mice. It is positively associated with lymphatic invasion, metastasis, late TNM stage, and a short overall survival time. However, the role of CNTN1 in cancer cell proliferation remains unclear. In addition, CNTN1 is involved in cancer cell invasion, migration, metastasis, and chemoresistance by promoting epithelial-mesenchymal transition and mediating several signal transduction pathways. Several studies suggest CNTN1 as a new therapeutic target for cancers. This review aims to summarize the research developments on CNTN1 in various cancers, to establish its role in epithelial-mesenchymal transition and signal transduction pathways, and to identify promising areas for further investigation.
ISSN:2234-943X
2234-943X
DOI:10.3389/fonc.2020.574208